Olema Pharmaceuticals (OLMA)
Develops oral therapies for breast cancer and other endocrine-driven tumors.
$8.93
vs last close−0.71 (−7.37%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 117.08% | 102.44M shares | |
|---|---|---|---|
| 201 holders · as of Jun 30, 2026 | |||
| Insiders | 2.18% | 1.91M shares | |
| 7 holders · as of Jul 27, 2026 | |||
| Strategic holders | 8.52% | 7.46M shares | |
| 2 holders · as of May 15, 2026 | |||
| Adds to | 127.78% | ||
87.50M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 127.78%; nothing is left for Other.
13F, as of Jun 30, 2026
201 holders · 102.44M shares · 26 new positions · 100 increased · 60 reduced · 39 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 12.14M | 13.88% | +1.76M | Aug 13, 2026 |
| Paradigm Biocapital Advisors LP | 8.67M | 9.91% | +650.0K | Aug 14, 2026 |
| Jupiter Topco LLC | 7.09M | 8.11% | +7.09Mnew | Aug 14, 2026 |
| Bain Capital Life Sciences Investors, LLC | 7.09M | 8.10% | −388.0K | Aug 14, 2026 |
| BlackRock, Inc. | 6.71M | 7.67% | +1.06M | Aug 7, 2026 |
| BVF Inc/IL | 5.30M | 6.05% | 0 | Aug 14, 2026 |
| Siren, L.L.C. | 4.86M | 5.55% | +100.0K | Aug 13, 2026 |
| State Street Corp | 4.32M | 4.93% | +378.2K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 12.50% | 10.00M | 13G | Mar 6, 2026 |
| Paradigm BioCapital Advisors LP | 9.99% | 7.43M | 13G | Feb 14, 2025 |
| Janus Henderson Group PLC | 8.20% | 7.11M | 13G | May 15, 2026 |
| Bain Capital Life Sciences Opportunities IV, L.P. | 8.15% | 7.47M | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 24, 2026 | Cyrus Harmondirector | Sale | 12,500 | $11.71 | 702,770 |
| Jul 23, 2026 | Cyrus Harmondirector | Sale | 12,500 | $11.58 | 715,270 |
| Mar 3, 2026 | Shawnte Mitchellofficer: CHIEF LEGAL OFFICER | Sale | 15,000 | $23.01 | 0 |
| Mar 4, 2026 | Shawnte Mitchellofficer: CHIEF LEGAL OFFICER | Sale · 2 lots | 25,000 | $24.25 | 233 |
| Jan 20, 2026 | Cyrus Harmondirector | Sale | 10,000 | $26.88 | 727,770 |
| Jan 14, 2026 | Cyrus Harmondirector | Sale | 3,489 | $29.12 | 737,770 |
| Jan 15, 2026 | Shane William Charles Kovacsofficer: CH. OPERATING & FINANCIAL OFF. | Sale | 100,000 | $28.73 | 139,727 |
| Jan 13, 2026 | Shane William Charles Kovacsofficer: CH. OPERATING & FINANCIAL OFF. | Sale | 3,822 | $28.01 | 239,727 |
| Jan 12, 2026 | David C. Mylesofficer: CH. DISCOV. & NON-CLIN DEV OFF | Sale | 10,000 | $28.34 | 144,846 |
| Jan 14, 2026 | David C. Mylesofficer: CH. DISCOV. & NON-CLIN DEV OFF | Sale · 2 lots | 50,000 | $28.87 | 542,761 |
House and Senate disclosures
Not reported.